Sorafenib Teva 200 mg filmom obložene tablete
| Name | Sorafenib Teva 200 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-665169629 |
| Active Substance | sorafenibtosilat |
| Composition | svaka filmom obložena tableta sadrži 200 mg sorafeniba (u obliku tosilata) |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Teva Operations Poland Sp. z o.o., Krakow, Poljska Merckle GmbH, Blaubeuren, Njemačka Pliva Hrvatska d.o.o., Zagreb, Hrvatska Actavis Group PTC ehf., Hafnarfjoerdur, Island |
| Marketing Authorisation Holder | Teva B.V., Swensweg 5, Haarlem, Nizozemska |
| Marketing Authorisation Date | 07.11.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/23-02/39 |
| Registration Number | 381-12-01/171-23-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L01EX02 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
